Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention

Mayo Clinic Proceedings

Volumn 82, Issue 2, 2007, Pages 186-195

  Croghan, Ivana T ^a   Hurt, Richard D ^a   Dakhil, Shaker R ^c   Croghan, Gary A ^a   Sloan, Jeff A ^b   Novotny, Paul J ^b   Rowland, Kendrith M ^d   Bernath, Albert ^e   Loots, Mary L ^f   Le Lindqwister, Nguyet A ^g   Tschetter, Loren K ^h   Garneau, Stewart C ^a,i   Flynn, Kathleen A ^j   Ebbert, Larry P ^k   Wender, Donald B ^l   Loprinzi, Charles L ^a  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c WICHITA COMMUNITY CLINICAL ONCOLOGY PROGRAM   (United States)

^d Carle Cancer Center CCOP   (United States)

^e GEISINGER MEDICAL CENTER   (United States)

^f Iowa Oncology Research Association CCOP   (United States)

^g Illinois Oncology Research Association CCOP   (United States)

^h Sioux Community Cancer Consortium   (United States)

ⁱ Cedar Rapids Oncology Project CCOP   (United States)

^j Ann Arbor Regional CCOP   (United States)

^k Rapid City Regional Oncology Group   (United States)

^l Siouxland Hematology Oncology Associates   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; PLACEBO;

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INHALER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COUNSELING; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 33846709883     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.2.186     Document Type: Article

References (27)

1. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000 [published corrections appear in JAMA 2005;293:293-294 and 298]. JAMA. 2004;291:1238-1245.
2. US Department of Health and Human Services, Public Health Service, Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence: Clinical Practice Guideline. Rockville, Md: US Dept of Health and Human Services, Public Health Service; June 2000.
3. Leischow SJ, Nilsson F, Franzon M, Hill A, Otte P, Mierikle EP. Efficacy of the nicotine inhaler as an adjunct to smoking cessation. Am J Health Behav. 1996;20:364-371.
4. Schneider NG, Olmstead R, Nilsson F, Mody FV, Franzon M, Doan K. Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction. 1996;91:1293-1306.
5. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo or smoking cessation. N Engl J Med. 1997;337:1195-1202.
6. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999;340:685-691.
7. Swan GE, McAfee T, Curry SJ, et al. Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch Intern Med. 2003;163:2337-2344.
8. Tonnesen P, Tonstad S, Hjalmarson A, et al. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. J Intern Med. 2003;254:184-192.
9. Tashkin D, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet. 2001;357:1571-1575.
10. Tonstad S, Farsang C, Klaene G, et al. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur Heart J. 2003;24:946-955.
11. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86:1119-1127.
12. Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addic Behav. 1978; 3:235-241.
13. Ware JE Jr, Sherbourne CD. The medical outcomes study 36-item short-form health survey (SF-36): conceptual framework and item selection. Med Care. 1992;30:473-483.
14. Radosevich DM, Wetzler H, Wilson SM. Health Status Questionnaire 2.0 (HSQ 2.0): Scoring Comparisons and Reference Data. Bloomington, Minn: Health Outcomes Institute; 1994.
15. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975;31:103-115.
16. Mayo Clinic Nicotine Research Program. Smoke-Free and Living It. Rochester, Minn: Mayo Foundation for Medical Education and Research; 2000.
17. Hughes JR, Grass JA, Pillitteri JL. Treatment resistant smokers: a pilot study of nicotine nasal spray and inhaler. J Addict Dis. 2000;19:95-100.
18. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;3: CD000146.
19. Okuyemi KS, Ahluwalia JS, Harris KJ. Pharmacotherapy of smoking cessation. Arch Fam Med. 2000;9:270-281.
20. Watts SA, Noble SL, Smith PO, Disco M. First-line pharmacotherapy for tobacco use and dependence. J Am Board Fam Pract. 2002;15:489-497.
21. Prochazka AV. New developments in smoking cessation. Chest. 2000; 117(4, suppl 1):169S-175S.
22. Hurt RD, Krook JE, Croghan IT, et al. Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. J Clin Oncol. 2003;21:914-920.
23. Gonzales DH, Nides MA, Ferry LH, et al. Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study. Clin Pharmacol Ther. 2001;69:438-444.
24. Tonnesen P, Norregaard J, Sawe U, Simonsen K. Recycling with nicotine patches in smoking cessation. Addiction. 1993;88:533-539.
25. Hays JT, Hurt RD, Rigotti NA, et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation: a randomized, controlled trial. Ann Intern Med. 2001;135:423-433.
26. Fu SS, Sherman SE, Yano EM, van Ryn M, Lanto AB, Joseph AM. Ethnic disparities in the use of nicotine replacement therapy for smoking cessation in an equal access health care system. Am J Health Promet. 2005;20:108-116.
27. Murray RP, Connett JE, Buist AS, Gerald LB, Eichenhorn MS. Experience of Black participants in the Lung Health Study smoking cessation intervention program. Nicotine Tob Res. 2001;3:375-382.